First AstraZeneca Vaccines Under COVAX Facility Arrives in Indonesia
According to Indonesian Minister of Foreign Affairs Retno LP Marsudi, these 1.113.600 AstraZeneca-vaccines, with a total weight of 4,1 tons, were the first shipment of the first batch via the COVAX facility.
COVAX facility is a multilateral collaboration seeking to ensure equitable global access to COVID-19 vaccination and has 92 member countries.
Retno, who is also a co-chair of the multilateral vaccine cooperation program COVAX Advance Market Commitment (AMC) Engagement Group (EG), added that Indonesia would receive 11.704.800 doses of the vaccine in finished form until May 2021.
The arrival of AstraZeneca vaccine was the sixth batch of all vaccine shipments in Indonesia.
Previously, the first batch of COVID-19 vaccine from Sinovac in finished form, arrived in Indonesia on 6 December 2020 – total 1.2 million doses. Afterwards, on the second batch Indonesia received 1.8 million doses of Sinovac vaccine on 31 December.
On 12 January on the third batch, Indonesia secured 15 million doses of Sinovac vaccine in raw form.
On the fourth batch, Indonesia received again 10 million doses of raw material of Sinovac vaccine. The last, on the fifth batch, 10 millions of raw material of Sinovac vaccine one more time landed in Indonesia. (DND/UN) (AP/EP)